Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension

Pulmonary Circulation

Volumn 4, Issue 1, 2014, Pages 61-70

  Swift, Andrew J ^a,b   Telfer, Adam ^a   Rajaram, Smitha ^a   Condliffe, Robin ^b,c   Marshall, Helen ^a,b   Capener, Dave ^a   Hurdman, Judith ^c   Elliot, Charlie ^b,c   Kiely, David G ^b,c   Wild, Jim M ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiac output; Dynamic contrast enhanced; Magnetic resonance imaging; Prognosis; Pulmonary arterial hypertension; Pulmonary vascular resistance

Indexed keywords

EID: 85026339387     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1086/674882     Document Type: Article

References (28)

1. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106(12):1477-1482.
2. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve´ P, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40(4):780-788.
3. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaı¨ci A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122(2):156-163.
4. Sandoval J, Bauerle O, Palomar A, Gómez A, Martínez-Guerra ML, Beltrán M, Guerrero ML. Survival in primary pulmonary hypertension: validation of a prognostic equation. Circulation 1994;89(4):1733-1744.
5. Shors SM, Cotts WG, Pavlovic-Surjancev B, François CJ, Gheorghiade M, Finn JP. Heart failure: evaluation of cardiopulmonary transit times with time-resolved MR angiography. Radiology 2003;229(3):743-748.
6. Müller HM, Tripolt MB, Rehak PH, Groell R, Rienmüller R, Tscheliessnigg KH. Noninvasive measurement of pulmonary vascular resistances by assessment of cardiac output and pulmonary transit time. Invest Radiol 2000;35(12): 727-731.
7. Lakoma A, Tuite D, Sheehan J, Weale P, Carr JC. Measurement of pulmonary circulation parameters using timeresolved MR angiography in patients after Ross procedure. Am J Roentgenol 2010;194(4):912-919.
8. Ley S, Mereles D, Risse F, Grünig E, Ley-Zaporozhan J, Tecer Z, Puderbach M, Fink C, Kauczor HU. Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements. Eur J Radiol 2007;61(2):251-255.
9. Ohno Y, Koyama H, Nogami M, Takenaka D, Matsumoto S, Onishi Y, Matsumoto K, Murase K, Sugimura K. Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease. J Magn Reson Imaging 2008;28(4):887-899.
10. Sodani G, Sergiacomi G, Orlando A, Albani E, Romagnoli A, Squillaci E, Masala S, Simonetti G. Perfusion MRI of the lung: preliminary results in twenty healthy volunteers. Radiol Med 2002;103(1-2):45-54.
11. Baek HK, Park TH, Park JS, Seo JM, Park SY, Kim BG, Kim SO, Cha KS, Kim MH, Kim YD. Segmental tissue Doppler image-derived Tei index in patients with regional wall motion abnormalities. Korean Circ J 2010;40(3):114-118.
12. Jeong HJ, Vakil P, Sheehan JJ, Shah SJ, Cuttica M, Carr JC, Carroll TJ, Davarpanah A. Time-resolved magnetic resonance angiography: evaluation of intrapulmonary circulation parameters in pulmonary arterial hypertension. J Magn Reson Imaging 2011 33(1):225-231.
13. Ohno Y, Hatabu H, Murase K, Higashino T, Nogami M, Yoshikawa T, Sugimura K. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. Am J Roentgenol 2007;188 (1):48-56.
14. Sergiacomi G, Bolacchi F, Cadioli M, Angeli ML, Fucci F, Crusco S, Rogliani P, et al. Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement. Radiology 2010;254(2):601-608.
15. Skrok J, Shehata ML, Mathai S, Girgis RE, Zaiman A, Mudd JO, Boyce D, et al. Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling. Radiology 2012;263(3):678-687.
16. Kiely DG, Elliot CA, Condliffe R. Pulmonary hypertension: diagnosis and management. BMJ 2013;346:f2028.
17. Korosec FR, Frayne R, Grist TM, Mistretta CA. Timeresolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36(3):345-351.
18. Peters AM. Fundamentals of tracer kinetics for radiologists. Br J Radiol 1998;71(851):1116-1129.
19. van Wolferen SA, Marcus JT, Boonstra A, Marques KMJ, Bronzwaer JGF, Spreeuwenberg MD, Postmus PE, Vonk-Noordegraaf A. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28(10):1250-1257.
20. Sandoval RG. Survival rate after cardiac arrest in community hospital. JAMA 1965;194(6):675-677.
21. Jang YM, Oh YM, Seo JB, Kim N, Chae EJ, Lee YK, Lee SD. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol 2008;43(6):403-410.
22. Francois CJ, Shors SM, Bonow RO, Finn JP. Analysis of cardiopulmonary transit times at contrast material-enhanced MR imaging in patients with heart disease. Radiology 2003; 227(2):447-452.
23. Gan CT, Lankhaar JW, Westerhof N, Marcus JT, Becker A, Twisk JW, Boonstra A, Postmus PE, Vonk-Noordegraaf A. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007;132 (6):1906-1912.
24. Swift AJ, Rajaram S, Condliffe R, Capener D, Hurdman J, Elliot C, Kiely DG, Wild JM. Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol 2012;47(10):571-577.
25. Swift AJ, Rajaram S, Marshall H, Condliffe R, Capener D, Hill C, Davies C, et al. Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension. Eur Radiol 2012;22(3):695-702.
26. Fink C, Ley S, Risse F, Eichinger M, Zaporozhan J, Buhmann R, Puderbach M, Plathow C, Kauczor HU. Effect of inspiratory and expiratory breathhold on pulmonary perfusion: assessment by pulmonary perfusion magnetic resonance imaging. Invest Radiol 2005;40(2):72-79.
27. Kuzo RS, Pooley RA, Crook JE, Heckman MG, Gerber TC. Measurement of caval blood flow with MRI during respiratory maneuvers: implications for vascular contrast opacification on pulmonary CT angiographic studies. Am J Roentgenol 2007;188(3):839-842.
28. Eichenberger AC, Schwitter J, McKinnon GC, Debatin JF, von Schulthess GK. Phase-contrast echo-planar MR imaging: real-time quantification of flow and velocity patterns inthe thoracic vessels induced by Valsalva’s maneuver. J Magn Reson Imaging 1995;5(6):648-655.